Global Therapeutic Vaccines Market

Therapeutic Vaccines Market Size, Share, Growth Analysis, By Product Type(Autoimmune Disease Vaccines, Addiction Vaccines, Neurological Disease Vaccines, Infectious Disease Vaccines), By Type(Protein-based Vaccines, DNA Vaccines, Recombinant Vector Vaccines, Conjugate Vaccines), By Application(Cancer, HIV/AIDS Vaccines, Infectious Diseases Vaccines, Allergy Vaccines), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35J2111 | Region: Global | Published Date: May, 2024
Pages: 215 |Tables: 95 |Figures: 78

Therapeutic Vaccines Market Insights

Global Therapeutic Vaccines Market size was valued at USD 25.7 billion in 2022 and is poised to grow from USD 53.71 billion in 2023 to USD 119.39 billion by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).

Therapeutic vaccines are given to the patient undergoing treatment from disease to strengthen immune response and promote better recovery. Growing use of therapeutic vaccine to improve the chances of successful treatment of patients affected with chronic diseases is driving market growth, High incidence of chronic diseases and rising investments in R&D of novel vaccines are also forecasted to benefit sales of therapeutic vaccine in the future. Rising awareness regarding preventive healthcare and growing demand for personalized medicine around the world are also estimated to boost the demand for therapeutic vaccine over the coming years. On the contrary, complexity in research and development process and limited efficacy are projected to be key restraints for therapeutic vaccine market development in the long run. Therapeutic vaccine companies can open up new avenues of opportunities by integrating their products with different immunotherapies and precision medicine going forward.

Market Snapshot - 2024-2031

Global Market Size

USD 25.7 billion

Largest Segment

Infectious Disease Vaccines

Fastest Growth

Autoimmune Disease Vaccines

Growth Rate

10.5% CAGR

Global Therapeutic Vaccines Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Therapeutic Vaccines Market Segmental Analysis

The global therapeutic vaccines market is segmented based on product type, application, type, and region. In terms of product type, the market is bifurcated into autoimmune disease vaccines, addiction vaccines, neurological disease vaccines, and infectious disease vaccines. Based on application, the market is divided into cancer, HIV/AIDS vaccines, infectious diseases vaccines, allergy vaccines, and others. In terms of type, the market is segmented into protein-based vaccines, DNA vaccines, recombinant vector vaccines, conjugate vaccines, and live attenuated vaccines. Based on region, the market is segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa.

Analysis by Product Type

Infectious disease vaccine is projected to account for a major share of the global therapeutic vaccine market. Rising incidence of infectious diseases and increasing efforts of governments to limit the spread of such diseases is projected to bolster market growth via this segment. The recent outbreak of COVID-19 is a prime example of how important vaccines are for infectious disease outbreaks.

Sales of autoimmune disease vaccines are projected to increase at a rapid pace over the coming years. Growing prevalence of autoimmune diseases and rising demand for the treatment of the same are aiding market development via this segment.

Global Therapeutic Vaccines Market By Product Type, 2022 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Therapeutic Vaccines Market Regional Insights

North America is estimated to account for a substantial share of the global therapeutic vaccines market owing to the presence of a developed healthcare ecosystem and high healthcare expenditure. Growing investments in R&D of novel therapeutic vaccines in this region will also aid the dominance of this region in the global market. The United States is projected to spearhead the demand for therapeutic vaccine in North America followed by Canada across the forecast period and beyond. An established clinical trial and regulatory approval system in the United States helps therapeutic vaccine market growth.

Meanwhile, the demand for therapeutic vaccines in the Asia Pacific region is slated to rise at a rapid pace over the coming years. Growing emphasis on preventive healthcare and rising availability of therapeutic vaccine are estimated to augment the demand for therapeutic vaccines in this region going forward. Countries such as India, China, Japan, and Indonesia are estimated to emerge as highly rewarding markets for therapeutic vaccine suppliers in the long run.

Global Therapeutic Vaccines Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Therapeutic Vaccines Market Dynamics

Drivers

High Emphasis on Preventive Healthcare

  • Surge in incidence of infectious and chronic diseases around the world has increased awareness regarding preventive healthcare among people around the world, which in turn, is forecasted to benefit sales of therapeutic vaccines.

High Investments in Vaccine R&D

  • Private and public health organizations are investing heavily in the research and development of novel therapeutic vaccines to improve healthcare accessibility around the world and reduce mortality rates.

Restraints

Complex Regulatory Approval Process

  • Therapeutic vaccines need to undergo rigorous approval and testing procedures before they are approved to be used on patients around the world. This lengthy and complex approval process slows down time-to-market and impedes market growth.

Limited Efficacy

  • Therapeutic vaccines play a crucial role in modifying the immune response to a disease, but their efficacy is subject to a lot of factors such as disease stage, age, and immune status of a patient. This limited efficacy could also hurt sales of therapeutic vaccines going forward.

Request Free Customization of this report to help us to meet your business objectives.

Therapeutic Vaccines Market Competitive Landscape

Therapeutic vaccine manufacturers should invest heavily in R&D of new vaccines that are more effective than what’s currently available in the market. Therapeutic vaccine companies can also collaborate and partner with each other to fast track the development of new vaccines and reduce time-to-market. Mergers and acquisitions are also popular strategies that could help therapeutic vaccine market players maximize their market share and presence.

Top Player’s Company Profiles

  • Novartis
  • Argos Therapeutics
  • Johnson & Johnson
  • Pfizer
  • Vaccinogen Inc.
  • Affiris
  • Antigenics
  • Bavarian Nordic
  • Biovest International
  • AstraZeneca
  • Merck & Co.
  • Dynavax Technologies Corporation
  • GlaxoSmithKline
  • Sanofi
  • Intellect Neurosciences
  • Agenus Inc.
  • Celldex Therapeutics
  • Cel-Sci
  • Curevac
  • Celtic Pharma
  • CSL Limited
  • Medimmune

Recent Developments

  • In February 2024, a clinical trial for mRNA-4359 cancer vaccine was launched in the United Kingdom. The trial is sponsored by Moderna, a leading pharmaceutical company and is projected to test the vaccine on patients from around the world over the next three years.
  • In January 2024, Elicio Therapeutics, a clinical-stage biotechnology company based in the United States, revealed its preclinical data regarding how its therapeutic cancer vaccine boosted the efficacy of T cell receptor-modified T-cell (TCR-T) therapy in mice.

Therapeutic Vaccines Key Market Trends

  • Use in Immunotherapy: Therapeutic vaccine vendors can focus on developing new products that can be used in specific immunotherapies to improve the treatment and efficacy rate among cancer patients. Therapeutic vaccine companies can modify immune responses as per tumor and improve the chances of successful immunotherapy.

Therapeutic Vaccines Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per Skyquest analysis, rising incidence of infectious and chronic diseases and growing emphasis on preventive healthcare are forecasted to bolster the demand for therapeutic vaccines across the forecast period. Lengthy approval procedures and limited efficacy are projected to be major restraints for therapeutic vaccine market development in the future. North America is slated to account for a robust share of the global therapeutic vaccine market owing to high healthcare spending and medical R&D activity. Therapeutic vaccine companies can focus on the development of specialized products aimed to improve the efficacy of immunotherapies for cancer.

Report Metric Details
Market size value in 2022 USD 25.7 billion
Market size value in 2031 USD 119.39 billion
Growth Rate 10.5%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product Type
    • Autoimmune Disease Vaccines, Addiction Vaccines, Neurological Disease Vaccines, Infectious Disease Vaccines
  • Type
    • Protein-based Vaccines, DNA Vaccines, Recombinant Vector Vaccines, Conjugate Vaccines, Live Attenuated Vaccines
  • Application
    • Cancer, HIV/AIDS Vaccines, Infectious Diseases Vaccines, Allergy Vaccines, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Novartis
  • Argos Therapeutics
  • Johnson & Johnson
  • Pfizer
  • Vaccinogen Inc.
  • Affiris
  • Antigenics
  • Bavarian Nordic
  • Biovest International
  • AstraZeneca
  • Merck & Co.
  • Dynavax Technologies Corporation
  • GlaxoSmithKline
  • Sanofi
  • Intellect Neurosciences
  • Agenus Inc.
  • Celldex Therapeutics
  • Cel-Sci
  • Curevac
  • Celtic Pharma
  • CSL Limited
  • Medimmune
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Therapeutic Vaccines Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Therapeutic Vaccines Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Therapeutic Vaccines Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Therapeutic Vaccines Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Therapeutic Vaccines Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Therapeutic Vaccines Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Therapeutic Vaccines Market size was valued at USD 25.7 billion in 2022 and is poised to grow from USD 53.71 billion in 2023 to USD 119.39 billion by 2031, growing at a CAGR of 10.5% in the forecast period (2024-2031).

Therapeutic vaccine manufacturers should invest heavily in R&D of new vaccines that are more effective than what’s currently available in the market. Therapeutic vaccine companies can also collaborate and partner with each other to fast track the development of new vaccines and reduce time-to-market. Mergers and acquisitions are also popular strategies that could help therapeutic vaccine market players maximize their market share and presence. 'Novartis', 'Argos Therapeutics', 'Johnson & Johnson', 'Pfizer', 'Vaccinogen Inc.', 'Affiris', 'Antigenics', 'Bavarian Nordic', 'Biovest International', 'AstraZeneca', 'Merck & Co.', 'Dynavax Technologies Corporation', 'GlaxoSmithKline', 'Sanofi', 'Intellect Neurosciences', 'Agenus Inc.', 'Celldex Therapeutics', 'Cel-Sci', 'Curevac', 'Celtic Pharma', 'CSL Limited', 'Medimmune'

Surge in incidence of infectious and chronic diseases around the world has increased awareness regarding preventive healthcare among people around the world, which in turn, is forecasted to benefit sales of therapeutic vaccines.

Use in Immunotherapy: Therapeutic vaccine vendors can focus on developing new products that can be used in specific immunotherapies to improve the treatment and efficacy rate among cancer patients. Therapeutic vaccine companies can modify immune responses as per tumor and improve the chances of successful immunotherapy.

North America is estimated to account for a substantial share of the therapeutic vaccines market owing to the presence of a developed healthcare ecosystem and high healthcare expenditure. Growing investments in R&D of novel therapeutic vaccines in this region will also aid the dominance of this region in the market. The United States is projected to spearhead the demand for therapeutic vaccine in North America followed by Canada across the forecast period and beyond. An established clinical trial and regulatory approval system in the United States helps therapeutic vaccine market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Therapeutic Vaccines Market

Product ID: SQMIG35J2111

$5,300
BUY NOW GET FREE SAMPLE